Programmed Death-Ligand 1 Expression in Sarcomas, a Clinical a Pathologic Study

被引:0
|
作者
Matthew, Stemm [1 ]
Mackinnon, Alexander C. [1 ]
机构
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
78
引用
收藏
页码:22A / 23A
页数:2
相关论文
共 50 条
  • [1] Programmed Death-Ligand 1 Expression in Sarcomas, a Clinical a Pathologic Study
    Matthew, Stemm
    Mackinnon, Alexander C.
    LABORATORY INVESTIGATION, 2016, 96 : 22A - 23A
  • [2] Status of programmed death-ligand 1 expression in sarcomas
    Park, Hyung Kyu
    Kim, Mingi
    Sung, Minjung
    Lee, Seung Eun
    Kim, Yu Jin
    Choi, Yoon-La
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [3] Status of programmed death-ligand 1 expression in sarcomas
    Hyung Kyu Park
    Mingi Kim
    Minjung Sung
    Seung Eun Lee
    Yu Jin Kim
    Yoon-La Choi
    Journal of Translational Medicine, 16
  • [4] Programmed death-ligand 1 expression in rectal cancer
    Jomrich, G.
    Silberhumer, G. R.
    Marian, B.
    Beer, A.
    Muellauer, L.
    EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, 2016, 48 (06): : 352 - 356
  • [5] Programmed death-ligand 1 expression in rectal cancer
    G. Jomrich
    G. R. Silberhumer
    B. Marian
    A. Beer
    L. Müllauer
    European Surgery, 2016, 48 : 352 - 356
  • [6] Programmed Death-1 and Programmed Death-Ligand 1 Expression Patterns in Pediatric Lymphoma
    Tamura, Akihiro
    Yoshida, Makiko
    Yamamoto, Nobuyuki
    Nino, Nanako
    Nakatani, Naoko
    Ichikawa, Takayuki
    Nakamura, Sayaka
    Saito, Atsuro
    Kozaki, Aiko
    Kishimoto, Kenji
    Ishida, Toshiaki
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    BLOOD, 2018, 132
  • [7] Programmed Death-Ligand 1 and Programmed Death-Ligand 2 Expression Can Affect Prognosis in Extramammary Paget's Disease
    Kawaguchi, Aya
    Akiba, Jun
    Kondo, Reiichiro
    Sadashima, Eiji
    Ogasawara, Sachiko
    Naito, Yoshiki
    Kusano, Hironori
    Sanada, Sakiko
    Muto, Ikko
    Nakama, Takekuni
    Yano, Hirohisa
    ANTICANCER RESEARCH, 2021, 41 (01) : 219 - 226
  • [8] Clinicopathological features of thymoma with the expression of programmed death-ligand 1
    Hakiri, S.
    Fukui, T.
    Mori, S.
    Kawaguchi, K.
    Nakamura, S.
    Ozeki, N.
    Kato, T.
    Goto, M.
    Yatabe, Y.
    Yokoi, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] Programmed death-ligand 1 expression in carcinoma of unknown primary
    Kim, Hye Min
    Koo, Ja Seung
    BMC CANCER, 2024, 24 (01)
  • [10] Clinical characteristics of Korean lung cancer patients with programmed death-ligand 1 expression
    Park, H-Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S25 - S25